ColE9 is a plasmid-encoded protein antibiotic produced by Escherichia coli and closely related species that kills E. coli cells expressing the BtuB receptor. The 15-kDa cytotoxic DNase domain of colicin E9 preferentially nicks double-stranded DNA at thymine bases and shares a common active-site structural motif with a variety of other nucleases, including the H-N-H homing endonucleases and the apoptotic CAD proteins of eukaryotes. Studies of the mechanism by which the DNase domain of ColE9 reaches the cytoplasm of E. coli cells are limited by the lack of a rapid, sensitive assay for the DNA damage that results. Here, we report the development of an SOS promoter-lux fusion reporter system for monitoring DNA damage in colicin-treated cells and illustrate the value of this reporter system in experiments that probe the mechanism and time required for the DNase domain of colicin E9 to reach the cytoplasm.
Colicins are plasmid-encoded antibacterial proteins that are secreted as part of the stress response system of Escherichia coli to kill other bacteria. They are classified into groups on the basis of the cell surface receptor on the target cells to which they bind. The E colicins all bind to the product of the chromosomal btuB gene, an outer membrane protein that is an essential component of the high-affinity transport system for vitamin B 12 in E. coli, and they require the outer membrane protein OmpF as a coreceptor (13) . Based on immunity tests, the E group colicins have been subdivided into nine types, ColE1 to ColE9. These fall into one of three cytotoxic classes: the membrane-depolarizing, or pore-forming, agent ColE1 (7); the DNases, colicins E2, E7, E8, and E9 (6) ; and the RNases, colicins E3, E4, E5, and E6 (17, 20) . Cells producing enzymatic colicins protect themselves against the action of their own toxin by coproducing a tightly binding, inactivating immunity protein. The resulting colicin-immunity complex is released from the cells, and the immunity protein is lost from the complex upon entry into susceptible cells (13) .
In common with most colicins, the enzymatic E-type colicins consist of three functional domains. The killing activity is contained in the C-terminal domain, which can be isolated as a stable and active protein (11, 14, 21, 31) . The central section contains the receptor-binding (R) domain, while the N-terminal T domain is responsible for translocation of the cytotoxic domain into the cytoplasm of the target cell (1, 10) . After binding to their outer membrane receptors, group A colicins, such as colicin E9, are translocated across the membrane in a process that is mediated by the tol system (1, 10) . Translocation requires a specific pentapeptide sequence in the T domain, known initially as the TolA box, which is now known to interact with TolB. ColE9 contains a TolB box from residues 35 to 39, DGSGW, which has been shown by mutagenesis to be important for its killing action and for the interaction of the T domain with the translocation protein TolB. The mechanism by which TolB recognizes and specifically binds to the TolB box sequence is unknown; however, recent nuclear magnetic resonance experiments have shown that the T domain of colicin E9 contains a large structurally disordered region that possesses a high degree of flexibility (5) . The X-ray structure of the RNase colicin E3 (26) did not reveal any resolved electron density for residues 1 to 83, a region of the T domain whose sequence is highly conserved in the enzymatic E colicins and thus might be expected to be similarly flexible.
The events that take place after receptor binding are speculative but presumably require the entry of at least part of the T domain of a tol-dependent colicin into the periplasm of the target E. coli cell, where it can interact with Tol proteins, such as TolB (4) , and in some way open a pathway in the outer membrane that allows entry of the cytotoxic domain. Poreforming colicins, such as colicin A, are then inserted into the cytoplasmic membrane, where they form voltage-gated membrane channels that depolarize and kill target E. coli cells. In vitro studies with planar lipid bilayers have allowed the opening and closing of channels to be monitored over short time periods (seconds). The formation of membrane channels by the pore-forming colicins can also be monitored in vivo by measuring potassium efflux, which occurs after a lag time of 3 min at 25°C and about 30 s at 37°C (3).
The 15-kDa DNase domain of colicin E9 preferentially nicks double-stranded DNA at thymine bases (23) and shares a common active-site structural motif with a variety of other nucleases, including the H-N-H homing endonucleases (23) (24) (25) and the apoptotic CAD proteins of eukaryotes (29) . Information on the mechanism by which the DNase domain of enzymatic colicins reaches the cytoplasm is very limited. It was recently reported that the DNase domains of colicin E9 and E2 exhibit channel-forming activity in planar lipid bilayers in vitro that appears to be involved in the process by which the cytotoxic domain crosses the cytoplasmic membrane of E. coli cells (19) . One of the problems in studying the entry of the DNase domain in vivo is the lack of a rapid, sensitive assay for the DNA damage that results. Conventional assays are all based upon the cell-killing activities of nuclease colicins and monitor either inhibition of growth over time via measurements of optical density at 600 nm (OD 600 ) or the production of a clear cell lysis zone as a result of spotting dilutions of purified colicin preparations onto a lawn of susceptible cells. Transcriptional profiling of E. coli cells treated with colicin E9 for 10 min has revealed strong induction of 28 genes of the LexA-regulated SOS response, which is a direct consequence of the DNA damage inflicted (28) . However, this method is not convenient for routine use. Here, we report the development of an SOS promoter-lux fusion reporter system for monitoring DNA damage in colicin-treated cells and illustrate the value of this reporter system in experiments that probe the mechanism and time required for the DNase domain of colicin E9 to reach the cytoplasm.
MATERIALS AND METHODS
Plasmids, bacterial strains, and media. E. coli JM83 (ara [⌬lac-proAB] rpsL 80lacZ⌬M15) was used as the host strain for cloning and mutagenesis. E. coli BL21(DE3) or ER2566 (Novagen) was used as the host strain for the expression vector pET21a (Novagen), which has a strong IPTG-inducible T7 polymerase promoter and a C-terminal polyhistidine tag (His tag) to facilitate the purification of overexpressed proteins. E. coli DPD1718 contains a fusion of the E. coli recA promoter region to the Photorhabdus luminescens luxCDABE reporter integrated into the lacZ locus of E. coli DPD1692 (8) . E. coli DPD2377 is E. coli DM800(pDEW634) that contains a plasmid-borne yigN fusion to the P. luminescens luxCDABE reporter (27) . All cultures were routinely grown in LuriaBertani (LB) broth or on plates of LB agar, supplemented where required with ampicillin (100 g ml Ϫ1 ) or chloramphenicol (30 g ml Ϫ1 ). Plasmid pNP69 encodes the colicin E9 structural gene (ceaI) and the Im9 immunity gene (ceiI), followed by a C-terminal His tag, under the control of an inducible T7 promoter in pET21a. In experiments in which the effects of other DNase immunity proteins were investigated, the plasmids were pTrc99A (Pharmacia Biotech) constructs containing the respective immunity proteins as previously described (16) . For the synchronization and protection experiments, we used a disulfide-locked colicin E9 construct, BH29, encoded by plasmid pBH29. This protein contains two cysteine mutations in the ColE9 receptor-binding domain that, in the reduced protein, do not affect its colicin activity. Formation of a disulfide bond under oxidizing conditions leads to loss of biological activity, as previously described (22) . Plasmid pAG1 is derived from pML261 and contains a 2.4-kb EcoRIHindIII fragment that encodes the complete btuB gene in the vector pUC8 (15) .
Protein purification. pET vectors (Novagen) encoding ColE9 and its mutants, along with a polyhistidine-tagged Im9, were transformed into E. coli BL21(DE3) cells. ColE9/Im9 complexes were purified as previously described by metal chelate chromatography (10) with a phosphate-buffered saline elution buffer containing 0.5 M NaCl and 1 M imidazole, pH 7.4. Protein concentrations were determined by absorbance at 280 nm.
Where necessary, the Im9 protein was removed from the ColE9/Im9 complex by diluting the complex 1:2 in 6 M guanidine HCl, 2 mM dithiothreitol (DTT), followed by preparative Sephacryl S-100 size exclusion chromatography as previously described (30). Free colicin E9 was then refolded by extensive dialysis against phosphate-buffered saline, pH 7.4, and stored. The BH29/Im9 complex was treated in a similar way but was refolded by dialysis against phosphatebuffered saline, pH 7.4, containing 1 mM DTT and stored in the presence of 10 mM DTT.
Diamide oxidation and DTT reduction. Protein samples were dialyzed overnight against phosphate-buffered saline, pH 7.4, to remove the DTT and were then incubated with 1 mM diamide (N,N,NЈ,NЈ-tetramethylazodicarbamide) for 30 min in the dark at room temperature before extensive dialysis against phosphate-buffered saline, pH 7.4. For reduction, the protein samples were incubated with 10 mM DTT for 1 h at ambient temperature, followed by extensive dialysis against degassed phosphate-buffered saline, pH 7.4. To avoid the possibility of spontaneous oxidation during certain assays, reduced protein was alkylated using iodoacetamide (50 mM final concentration), followed by extensive dialysis.
Reporter assay conditions. All assays were done at 37°C using a microtiter plate luminometer (Lucy 1; Anthos Labtech, Salzburg, Austria), and the media, plates, and luminometer were prewarmed to this temperature to minimize the induction of a stress response due to cooling effects. Reporter strains were plated out fortnightly from frozen stocks, and single colonies were picked for overnight cultures and grown in the presence of appropriate antibiotics. Overnight cultures were diluted 1:50 and grown for 3 hours at 37°C (OD, ϳ0.35 to 0.4), after which they were diluted 1:2 (100-l total volume) into black 96-well plates with an optical bottom (Nunc) and with ColE9 or mutant protein added. Unless stated otherwise, colicin-immunity protein complexes were used for these experiments. Induction of luminescence was followed over a period of 1.5 to 3 hours, with readings taken every 300 or 600 s. Cell density was recorded via OD 492 values.
In the experiments in which the effects of immunity proteins were investigated in the presence of IPTG, the cells were grown to an OD 600 of 0.2, 1 mM IPTG was added, and the cells were incubated for another hour at 37°C, after which they were diluted 1:2 in 96-well plates as described above. For protease protection experiments, oxidized BH29 (free protein) was added to DPD1718 (OD 600 , ϳ0.3) in a 96-well plate at a final concentration of 0.4 nM. After 30 min, cell killing was induced by adding 1 mM DTT, and trypsin was added at regular time intervals between 0 min and 20 min at a final concentration of 0.05 mg/ml. Data analysis. Luminescence values are mostly presented as relative luminescence units (RLU). The ratio of RLU over OD values was taken for the calculation of the "gamma," values that were used to generate the dose-response curve and to represent the amount of protection offered by the immunity proteins or trypsin treatment. The gamma value is defined as the luminescence induced for any given sample concentration minus the luminescence of the control cells at the same time point divided by the luminescence of the control cells at that time point: (L sample Ϫ L control )/L control (8) . We mostly chose an arbitrary time point of 50 min for the calculation of the gamma value unless stated otherwise. All assays were performed at least twice with three to six replicates for each condition. Error bars, where shown, represent the standard error of the mean for at least two independent experiments.
RESULTS
Development of a lux-based DNA damage assay for ColE9. Transcriptional profiling of E. coli cells treated with colicin E9 for 10 min revealed the up-regulation of 28 genes of the LexAregulated SOS response (28) . A reporter system linked to transcription of any of these 28 genes should be specific for the DNA damage induced by ColE9. We investigated two previously described lux-based reporter strains that had been developed to assay genotoxicity. E. coli DPD1718 contains a fusion of the E. coli recA promoter region to the Photorhabdus luminescens luxCDABE reporter integrated into the lacZ locus of E. coli DPD1692 (8), while E. coli DPD2377 is E. coli DM800(pDEW634) that contains a plasmid-borne yigN fusion to the P. luminescencs luxCDABE reporter (27) . For the initial characterization of the reporter strains, we used the known SOS response inducers mitomycin C (a DNA-alkylating agent) and nalidixic acid (a DNA gyrase inhibitor), as previously described (8) . The chromosomal fusion was chosen for further studies because it gave a lower background and wider range of activity than the plasmid-borne reporter (data not shown).
The data in Fig. 1 show the change in cell density compared to the change in luminescence with time after the addition of 3 nM ColE9 to E. coli DPD1718 cells. An increase in lumines- VOL. 187, 2005 DNA DAMAGE-INDUCIBLE REPORTER SYSTEM 4901 cence over the background can be detected as early as 15 min after addition of colicin E9, with a maximum reached after about 1 hour. By reducing the sampling time, we detected an increase in luminescence after 11 min (data not shown). Previous reports with similar genotoxicity reporter systems had suggested that up to 60 min was required to see a response to DNA damage induction (8) . The observed result is a significant improvement in the sensitivity of detection of DNA damage caused by ColE9 compared to the conventional cell growth assays in which OD 600 is routinely followed for 4 hours. Moreover, the traditional cell-killing assays monitor cell death, which is the final consequence of the DNA damage induced by ColE9 and which can be affected by DNA repair and other factors, which cannot always be controlled. The mechanism by which ColE9 induces the SOS response and thus results in bioluminescence in E. coli DPD1718 cells requires the generation of single-stranded DNA (ssDNA), which can be created by processing of DNA damage and stalled replication, and perhaps by other means (18) . The ssDNA acts as a signal that activates a dormant coprotease activity of RecA to facilitate the proteolytic self-cleavage of the LexA repressor, thus inducing the LexA regulon. We have shown previously that the ColE9 DNase has a preference for cleaving DNA after Ts and that runs of Ts are readily cut by the enzyme but runs of As are not (23) . The presence of runs of Ts in the E. coli genome may be the mechanism for generating the necessary ssDNA to activate the SOS response.
To characterize the detection limit and the linear range of our assay, we incubated E. coli DPD1718 with a range of ColE9/Im9 complex concentrations from 2 nM to 2 pM (final concentration) in serial twofold dilutions (Fig. 2, top) . At lower concentrations, the bioluminescence increased with time, while at higher ColE9 concentrations, the maximum RLU values were much higher but then rapidly declined. We assume that this is due to an effect on the generation of bioluminescence associated with the overwhelming of DNA repair systems and finally the loss of viability, and probably even cell lysis, caused by high concentrations of ColE9. Gamma values calculated at 50 minutes were used to generate the dose-response curve shown in Fig. 2 , bottom. The results showed that the assay is sensitive down to concentrations of 2 pM ColE9. In contrast, the spot test using purified ColE9/Im9 complex showed killing activity only to 1 nM (data not shown). Luminescence induction was linear over a concentration range from 0 to 0.5 nM (r 2 ϭ 0.99) (Fig. 2, bottom) . Higher colicin concentrations resulted in a response plateau, presumably because of the cell-killing action of ColE9. We have occasionally used colicin E9 concentrations outside the linear range in order to relate the results back to our conventional cell-killing assays (see below).
We investigated the specificity of luminescence induction by ColE9 by using two biologically inactive (devoid of cell-killing activity) mutants of ColE9. The H575A mutant is an active-site mutant of ColE9 that lacks DNase activity but still binds the outer membrane receptor BtuB and interacts with TolB (11, 29) . The D35A TolB box mutant of ColE9 is unable to interact with TolB but still has BtuB-binding and DNase activities comparable to those of wild-type ColE9 (10) . Both of these mutant proteins were unable to induce a bioluminescence response above the background in our reporter assay, even when used at a 10-fold-higher concentration (40 nM) than the wild-type ColE9 (4 nM). Together, these results indicate that the luminescence response is a consequence of ColE9 DNase activity in the cytoplasm of susceptible cells.
We isolated E. coli MV1710, a btuB mutant of the E. coli DPD1718 strain, by spotting 20-l aliquots of 40 nM ColE9 onto an overlay of DPD1718 and picking colonies growing within the resulting zone of lysis. Transformation of this mutant with plasmid pAG1, which encodes BtuB, restored sensitivity to ColE9 (data not shown). Loss of a functional BtuB receptor in the outer membrane resulted in loss of the luminescence response in E. coli MV1710, even when 10-foldhigher concentrations of ColE9 were used (Fig. 3, bottom) . When BtuB expression was restored via the pAG1 construct, lux induction was restored in the mutant reporter strain. The faster response of these cells may be related to the higher copy number of the pAG1-encoded btuB gene product in the outer membrane. It was shown previously that the amount of BtuB in the outer membrane of pAG1-bearing cells comprises about 20 to 40% of the outer membrane proteins (12) . The lower overall luminescence induction may indicate an imbalance between the amounts of BtuB receptor and proteins encoded by the tol operon that are required for translocation of ColE9 and/or a faster cell-killing action by ColE9 under these conditions. The shift to the left in the timing of the peak of induction perhaps suggests that the latter explanation is more likely. A 12-foldhigher background luminescence was observed in the pAG1-containing cells than in E. coli DPD1718 and E. coli MV1710 cells without pAG1.
Applications of the assay. (i) Protection by various immunity proteins-relation with K d.
A recent paper by Li et al. (16) compared the degrees of protection of bacteria against ColE9 activity by a set of immunity proteins (expressed intracellularly) whose affinities for the ColE9 DNase covered a range of 10 orders of magnitude. They used a spot test, a traditional cell-killing assay in which a series of decreasing concentrations of ColE9 are spotted onto a lawn of sensitive cells, and analyzed the numbers of surviving cells as a function of the affinities of the different immunity proteins for ColE9.
Since our assay is designed to investigate the DNA-damaging activities of DNase colicins in a more specific and sensitive way, we used it to look at a limited selection of these immunity [Im7]) compared to the empty control vector pTrc99A. We used two concentrations of ColE9: 0.4 nM, within the linear range of our assay, and 4 nM, a lethal concentration used in the conventional assays. Aliquots of all immunity-expressing E. coli DPD1718 cells, before and after IPTG induction, were run on 16% sodium dodecyl sulfatepolyacrylamide gel electrophoresis to check for protein expression. Similar amounts of the immunity proteins were produced after 1 hour of IPTG treatment (data not shown). The luminescence results are presented in Fig. 4 . The full protection offered by Im9 (K d , 10 Ϫ14 ) confirmed that the luminescence induction in our assay is a specific effect of the DNase activity of ColE9. Our data broadly support the analysis of Li et al. (16) , which indicated that immunity proteins with a K d of Ͼ10 Ϫ6 offer no protection and that the K d required for complete biological protection is Ͻ10 Ϫ10 M (Fig. 4) . (ii) Synchronized cell death using a "disulfide-locked" colicin E9 protein. We recently presented data showing that a mutant ColE9 protein (BH29) with an engineered disulfide bond in its receptor-binding domain (via two strategically positioned cysteine mutations) was inactive in the oxidized form and that activity was restored when it was reduced through the addition of DTT (22) . The current reporter assay, because of its faster response time and sensitivity, enabled us to probe the early events after DTT addition. The oxidized free protein (BH29) was incubated with cells for 45 min, at which time 1 mM DTT was added to certain wells. Reduced and alkylated free BH29 served as the positive control. Figure 5 shows resumption of colicin activity, as seen by a significant increase in luminescence above the background level of the oxidized protein a few minutes after addition of DTT that continued at a rate similar to that of the reduced and alkylated protein. The interval from the time of addition of reduced and alkylated BH29 until the 50% increase in the resulting luminescence was significantly longer than that seen after DTT addition to cells incubated with oxidized BH29, even though the latter must include the additional time taken for DTT to reduce BH29 before the cell-killing process can begin. The small increase in luminescence of the oxidized protein over the extended assay period is likely to be due to incomplete oxidation during preparation of the diamide-treated BH29 protein. Very similar findings were obtained when E. coli cells were preincubated with the oxidized protein for a fixed time, followed by removal of unbound protein by spinning and washing the cells in LB broth and addition of 1 mM DTT at the same time point as described above (data not shown). This suggests that DTT reduction of BH29 protein that is already bound to BtuB initiates the DNA damage and thus that some of the early events of receptor binding and even translocation have already occurred during incubation of E. coli cells with oxidized BH29.
(iii) Timing of cell death using protease protection. Limited digestion of ColE9 with trypsin under controlled conditions abolishes biological activity and results in three main cleavages, one at the N terminus of the translocation domain, one at the start of the receptor-binding domain, and one at the border of the receptor-binding and DNase domains (31) . Trypsin was used to investigate how long after the addition of DTT E. coli cells incubated with oxidized BH29 could be rescued from colicin action (Fig. 6, top) . Gamma values calculated at 60 min show that the amount of protection offered by trypsin activity decreased dramatically with increasing time lag between adding DTT (approximate time of initiation of colicin uptake) and trypsin (Fig. 6, bottom) . The data show that after 3.5 min, only 50% of the cells can be protected by trypsin, and after 10 min, the cells can no longer be rescued from colicin action. The amount of trypsin (0.05 mg/ml) used for these experiments did not affect the growth of the reporter strain (data not shown).
DISCUSSION
We wished to address some fundamental questions regarding the molecular details of the translocation of nuclease colicins, such as (i) when and how is the Im9 protein lost from the ColE9/Im9 complex; (ii) what is the temporal sequence of the translocation events, such as interaction of the T domain with TolB; and (iii) how does this result in the DNase domain crossing the outer membrane to reach the periplasm? Progress in understanding these questions has been hampered by the lack of a sensitive and rapid assay for the translocation of enzymatic E colicins, other than by monitoring the resulting growth inhibition. The luminescence assay described and validated here reports on the DNA damage inflicted by nuclease colicins once inside the cell and is thus an effective and sensitive surrogate for translocation. An analogous assay for the pore-forming colicins, based on their membrane-depolarizing capacity, has provided details about the timing and uptake pathway of these bacteriocins (2, 3, 9) .
Initial characterization of the two reporter strains led us to focus our efforts on E. coli DPD1718 due to its rapid response and lower overall background compared to E. coli DPD2377. This rapid response is slower than the potassium efflux response observed for some of the pore-forming colicins, such as colicin A, for which lag times of only 30 s before K ϩ efflux have been observed at 37°C (3). This is unlikely to be caused by differences in receptor binding and translocation, since similar proteins are involved for both colicins. There are, however, a number of factors that could explain the discrepancy. First, pore-forming colicins bind susceptible cells in the absence of their immunity protein whereas nuclease colicins bind to cells as a complex with their immunity protein, which implies that at some stage during uptake the immunity protein must be lost. We have been able to discard the possibility that loss of the immunity protein from the colicin complex is responsible for the increased time required to initiate the luminescence response, since E. coli DPD1718 cells treated with ColE9/Im9 complex showed a time response of lux induction nearly identical to that of cells treated with the free ColE9 protein (data not shown). The natures of the responses analyzed account for some of the observed time difference, i.e., potassium efflux is a relatively instantaneous process as opposed to the time required for the bioluminescence to be generated, which is the sum of the times necessary for sufficient DNA damage to be generated, SOS promoter activation, transcription, translation, and luminescence generation by the luciferase enzyme. Third, the different "end locations" of the pore-forming colicins (the inner membrane) and the nuclease colicins (the cytoplasm) could also be involved. It is as yet unknown how the cytotoxic domain of the nuclease colicins crosses the inner membrane to gain entry into the cytoplasm, although intrinsic channel activity of the nuclease domain has been suggested (19) .
Additional validation of the assay demonstrated a detection limit as low as 2 pM and a linear luminescence response range up to 0.5 nM ColE9. These are all significant improvements compared to the traditional cell-killing assay in terms of sensitivity, response speed, and ease of data analysis. ColE9 mu- (16) . This has reinforced the "dual-specificity" hypothesis within colicin DNase-immunity protein complexes with contributions from "binding energy hotspot" and "specificity-determining" residues, respectively (14) . The simplicity of the reporter assay compared with determining K d values will therefore enable us to rapidly and quantitatively assess the effects of individual mutations on the biological activity not only of the colicin molecule but also of the immunity protein (via assessment of the level of protection offered upon intracellular expression). It will be interesting to see the results of similar experiments with mutations introduced into the tolB gene of the reporter strain that reduce the affinity of binding for the TolB box of ColE9.
To help dissect the events that occur after colicin binding to the outer membrane receptor, we previously engineered a ColE9 construct containing a disulfide bridge in its receptorbinding domain under oxidizing conditions that resulted in the loss of its biological activity (22) . Since activity can be restored by the addition of DTT, this indicates a requirement for flexibility of the coiled-coil R domain of ColE9 for biological activity. It is not known whether the bound oxidized BH29 protein is "stalled" in its receptor-binding state or whether early stages of the translocation process may also have begun. We investigated this by incubating the oxidized BH29 protein with the reporter strain to allow receptor binding and then initiating cell-killing activity by the addition of DTT (Fig. 5) . The data from this experiment support the conclusion that bound BH29 initiates DNA damage with a shorter lag time than the reduced and alkylated BH29 control. This experimental approach was taken further by studying the effect of externally added protease (trypsin) and following the length of time available for this enzyme to rescue cells from colicin action after resumption of cell killing by addition of DTT (Fig. 6) . In order to obtain full protection, the trypsin had to be added very quickly after DTT addition. Trypsin added 3.5 min after reduction of the protein resulted in a luminescence response of 50% of the response of the reduced protein without trypsin, suggesting that perhaps more than half of the trypsin-sensitive sites (and thus presumably the DNase domain) are beyond the reach of the trypsin and have at least crossed the outer membrane. Results obtained with colicin A showed that trypsin addition as soon as 1 minute and up to 5 minutes after the onset of potassium efflux arrested the efflux (2). Cell viability, however, was conserved only if trypsin was added within the first 2 minutes (2). The response time of our assay did not allow us to investigate the protective effect of trypsin on such a short timescale, but our data suggest that entry of the cytotoxic domain of ColE9 into the cytoplasm is a very fast event that cannot be arrested by the addition of trypsin after it is initiated. It remains to be demonstrated whether any of the translocation events, such as the T domain crossing the outer membrane and interacting with TolB, have been initiated with bound oxidized BH29. The sensitive reporter assay that we have described in this work will facilitate the design of these experiments.
